About WIRB-Copernicus Group
WIRB-Copernicus Group is a company based in Princeton (United States) founded in 2012 was acquired by Leonard Green and Partners in November 2019. The company has 229 employees as of December 31, 2022. WIRB-Copernicus Group has completed 24 acquisitions, including ACI Clinical, Analgesic Solutions and Array. WIRB-Copernicus Group offers products and services including IRB Review, Site Enablement, and Recruitment Services. WIRB-Copernicus Group operates in a competitive market with competitors including Medidata, Verily, TriNetX, Signant Health and IXICO, among others.
- Headquarter Princeton, United States
- Employees 229 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Ares Capital Corporation
& 3 more
-
Employee Count
229
as on Dec 31, 2022
-
Investments & Acquisitions
ACI Clinical
& 23 more
-
Acquired by
Leonard Green and Partners
(Nov 12, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of WIRB-Copernicus Group
WIRB-Copernicus Group offers a comprehensive portfolio of products and services, including IRB Review, Site Enablement, and Recruitment Services.
Provides ethical and scientific review for clinical trials.
Optimizes sites for faster study start-up and management.
Supports enrollment and retention in clinical studies.
People of WIRB-Copernicus Group
Unlock access to complete
Unlock access to complete
Software Development Team
65 people
Operations Team
56 people
Leadership Team
46 people
Senior Team
36 people
Sales and Marketing
28 people
Project Team
19 people
Legal and Compliance
14 people
Finance and Accounting
14 people
Unlock access to complete
Funding Insights of WIRB-Copernicus Group
Investors in WIRB-Copernicus Group
WIRB-Copernicus Group has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Ares Capital Corporation, Arsenal Capital Partners and Novo Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital fund focused on the healthcare sector
|
Locked | Locked | Locked | |
|
Private equity and debt investments are managed for businesses.
|
Locked | Locked | Locked | |
|
Private equity investments target specialty industrials and healthcare sectors.
|
Locked | Locked | Locked |
Investor details for WIRB-Copernicus Group
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by WIRB-Copernicus Group
WIRB-Copernicus Group has strategically engaged in corporate development activities, having acquired 24 companies. Notable acquisitions include ACI Clinical, Analgesic Solutions and Array.
Investment portfolio details for WIRB-Copernicus Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
A digital platform is used for clinical trial contract collaboration.
|
Locked | Locked | 2021 | Locked | |
|
Provider of data management and site selection services
|
Locked | Locked | 2016 | Locked | |
|
Products and services to improve the informed consent process during clinical trials
|
Locked | Locked | 2015 | Locked |
Complete acquisition details for WIRB-Copernicus Group
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - WIRB-Copernicus Group
Detailed financials for WIRB-Copernicus Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Wirb-Copernicus Group Comparisons
Peer comparison for WIRB-Copernicus Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of WIRB-Copernicus Group
WIRB-Copernicus Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medidata, Verily, TriNetX, Signant Health and IXICO, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
|
|
| Locked | Locked | Locked |
AI-based solutions for health management are provided.
|
|
| Locked | Locked | Locked |
Clinical trial management software is provided for researchers and professionals.
|
|
| Locked | Locked | Locked |
Signant Health is engaged in providing clinical trial technology solutions.
|
|
| Locked | Locked | Locked |
AI-based medical image management and analysis solutions for healthcare organizations
|
Detailed competitors of WIRB-Copernicus Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Wirb-Copernicus Group
Complete news archive for WIRB-Copernicus Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about WIRB-Copernicus Group
WIRB-Copernicus Group was founded in 2012 and raised its 1st funding round 4 years after it was founded.
WIRB-Copernicus Group is headquartered in Princeton, United States. It is registered at Princeton, New Jersey, United States.
As of Dec 31, 2022, the latest employee count at WIRB-Copernicus Group is 229.
WIRB-Copernicus Group (WCG) is a global provider of regulatory and ethical review services (IRB) for human research to sponsors, CROs and institutions. They claim to review over 3,000 new protocols and over 15,000 new PIs annually. The company offers a unified Single Review Solution (SRS) catering to all sites involved in a clinical trial. All sites are reviewed under one Institutional Review Board (IRB) umbrella using the SRS process. Through SRS, clients can work with a single IRB and mange the IRB review process and related documentation in one place.The company claims to have reviewed over 250 studies and more than 9,000 sites using SRS and also that it is being used by several leading sponsors and CROs. WCG acquired ThreeWire, a patient recruitment and retention firm.
WIRB-Copernicus Group offers IRB Review, Site Enablement, and Recruitment Services.
WIRB-Copernicus Group has made 24 acquisitions, including ACI Clinical, Analgesic Solutions, and Array.
WIRB-Copernicus Group has 4 investors. Key investors include Ares Capital Corporation, Arsenal Capital Partners, Novo Holdings, and Leonard Green and Partners.